All you need to get started with ETF selection and analysis. Create your account now →

Help us improve your experience. Please confirm your investor type:

Global ETF Survey 2026

The ETF Industry Is Evolving Fast

From AI infrastructure to active strategies, the ETF landscape is shifting. Share your perspective in the 7th Annual Global ETF Survey.

Global ETF Survey 2026
MEDI

Harbor Health Care ETF

The MEDI Exchange Traded Fund (ETF) is provided by Harbor Capital. This fund is actively managed; it does not track an index. This share class generates a stream of income by distributing dividends.

Advertisement

Advertisement

$33.26
+$0.39 (+1.20%) today
2:23 PM 08/06/26 Open
1D price range
$33.26$33.26
52W price range
$25.99$34.89
YTD Perf.
+4.61%
YTD Flows
Annualized volatility
Fund AuM
€36M
Share class AuM
€36M
TTM Yield
Tracking Error
Tracking Difference
ISIN
US41151J8696
TER
0.8%
Inception date
11/16/2022
Dividend policy
Compare similar ETFs
API
PerformanceDec 31, 2025 - Aug 5, 2026
-10%-5%0%5%10%JANMARMAYJUL
Flows
Join for free to unlock
Data as of 06/30/26
Healthcare
83.80%
Unavailable
16.20%
Latest MEDI news

No content available for this fund

FAQ about MEDI

MEDI is a Active ETF. This ETF provides exposure to Other Health Care Equities.
MEDI carries a total expense ratio (TER) of 0.8%, indicating the annual cost for holding the fund.
MEDI was introduced to the market on November 16, 2022. It trades on United States
Harbor Health Care ETF, MEDI, is provided by Harbor Capital. Learn more about Harbor Capital here.
MEDI oversees €36M in assets as of August 5, 2026.
MEDI follows a distributing dividend policy, meaning it pays out income to investors. As of August 5, 2026, its 12-month trailing yield was 0.46%.
As of June 30, 2026, MEDI has significant geographic allocations in USA, Netherlands and France.
As of June 30, 2026, MEDI focuses largely on Healthcare.
As of June 30, 2026, MEDI holds 38 positions in its portfolio, with 74.21% of assets concentrated in its top 15 holdings.
As of June 30, 2026, MEDI top three holdings include Eli Lilly & Co., US04351P1012 and Gilead Sciences, Inc..
The base currency of MEDI is USD.
Data as of 06/30/26
Eli Lilly & Co.
21.09%
US04351P1012
14.15%
Gilead Sciences, Inc.
4.52%
Legend Biotech Corp.
4.37%
Rhythm Pharmaceuticals, Inc.
4.29%
AbbVie, Inc.
3.27%
Intuitive Surgical, Inc.
3.13%
Insmed, Inc.
2.84%
Revolution Medicines, Inc.
2.67%
Natera, Inc.
2.66%

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:
  • More fund data
  • Compare up to 3 funds
  • More screener filters
  • Edit screener columns from 100+ metrics
  • Watchlists for saving your research
  • Portfolio construction and analysis
  • Personal dashboard for live monitoring

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight